MCT4-Driven CAF-Mediated Metabolic Reprogramming in Breast Cancer Microenvironment Is a Vulnerability Targetable by miR-425-5p

Investigators assessed the expression of miR-425-5p and its target monocarboxylate transporter (MCT4) in breast cancer associated fibroblasts (CAFs) and normal fibroblasts.